Government to impose disciplinary fine for falsely reporting adverse drug reactions in clinical trials

If an institute or organization is exposed for a false report of adverse drug reactions during a clinical trial, a disciplinary fine will be imposed.

In order to keep patients participating in clinical trials safe and enlarge treatment options, the Ministry of Food and Drug Safety(MFDS) announced to strengthen regulations in regards to clinical trials.

First of all, in order to protect subjec...